Stock A251120 BIO-FD&C CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company BIO-FD&C Co.,Ltd.

Equities

A251120

KR7251120002

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 07/05/2024 BST 		5-day change 1st Jan Change
14,370 KRW +1.20% Intraday chart for BIO-FD&C Co.,Ltd. +0.49% +1.77%
2023 Tranche Update on BIO-FD&C Co.,Ltd.'s Equity Buyback Plan announced on October 19, 2022. CI
2023 Tranche Update on BIO-FD&C Co.,Ltd.'s Equity Buyback Plan announced on October 19, 2022. CI

Business Summary

Bio-FD&C Co Ltd is a Korea-based company mainly engaged in the and research, development and manufacture of plant cell derived active substances and plant cell derived pharmacological substances. The Company is mainly engaged in the manufacture and sale of soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, acanthopanax koreanum adventitious root culture extract. The Company's products are mainly used as materials for cosmeceuticals, health functional foods and pharmaceuticals.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Growth Factor Complex
42.1 %
5,717 36.1 % 6,569 42.1 % +14.91%
Plant Cell
22.5 %
4,870 30.7 % 3,503 22.5 % -28.07%
Plant Cell Complex
11.7 %
1,371 8.6 % 1,823 11.7 % +33.03%
Extract
9.6 %
1,165 7.3 % 1,500 9.6 % +28.85%
Protein
7.3 %
1,067 6.7 % 1,141 7.3 % +6.88%
Peptide
4.8 %
780 4.9 % 755 4.8 % -3.22%
Research Service
0.6 %
647 4.1 % 94 0.6 % -85.49%
Manufactured Products - Other
0.6 %
110 0.7 % 93 0.6 % -15.71%
Other
0.4 %
30 0.2 % 59 0.4 % +97.57%
Complex
0.4 %
99 0.6 % 55 0.4 % -44.56%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
81.8 %
12,898 81.3 % 12,757 81.8 % -1.09%
China
10.1 %
1,301 8.2 % 1,579 10.1 % +21.41%
Europe
3.5 %
743 4.7 % 540 3.5 % -27.34%
Others
2.9 %
740 4.7 % 446 2.9 % -39.70%
Japan
1.7 %
174 1.1 % 270 1.7 % +55.38%

Managers

Managers TitleAgeSince
Dae-Hyeon Jeong CEO
 Chief Executive Officer 52 31/12/04
Sang-Hyeon Mo CEO
 Chief Executive Officer 48 31/12/04
Chang-Myung Lee DFI
 Director of Finance/CFO 47 30/11/20
Il-Dong Kim AUD
 Comptroller/Controller/Auditor 54 31/12/10

Members of the board

Members of the board TitleAgeSince
Kyung-Mok Park BRD
 Director/Board Member 57 31/12/20
Sang-Hyeon Mo CEO
 Chief Executive Officer 48 31/12/04
Dae-Hyeon Jeong CEO
 Chief Executive Officer 52 31/12/04
Chang-Myung Lee DFI
 Director of Finance/CFO 47 30/11/20
Ki-Yup Baek BRD
 Director/Board Member 73 31/12/20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 8,695,700 4,984,367 ( 57.32 %) 166,751 ( 1.918 %) 57.32 %

Shareholders

NameEquities%Valuation
Sang-Hyeon Mo
14.30 %
1,243,200 14.30 % 12 M ₩
Dae-Hyeon Jeong
10.28 %
893,600 10.28 % 8 M ₩
GIVAUDAN SA
8.464 %
736,000 8.464 % 7 M ₩
SYL Holding Ltd.
5.474 %
476,000 5.474 % 4 M ₩
Jung-hoon Lee
2.214 %
192,560 2.214 % 2 M ₩
BIO-FD&C CO.,LTD.
1.918 %
166,751 1.918 % 2 M ₩
Young-tae Mo
1.780 %
154,800 1.780 % 1 M ₩
Su-jung Kim
1.693 %
147,200 1.693 % 1 M ₩
Bio-FD&C Co., Ltd. ESOA
0.9068 %
78,854 0.9068 % 738 021 ₩
Jung-nam Kim
0.4232 %
36,799 0.4232 % 344 414 ₩

Holdings

NameEquities%Valuation
BIO-FD&C CO.,LTD.
1.92%
 166,751 1.92% 1,560,678 $

Company contact information

Bio-FD&C Co., Ltd.

Unit509-512 & B07, Smart Valley A 30 Songdomirae-ro

21990, Inchon

+

http://www.biofdnc.com
address BIO-FD&C Co.,Ltd.(A251120)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
BIO-FD&C CO.,LTD. Stock BIO-FD&C Co.,Ltd.
+1.77% 91.03M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.95% 700B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.97% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.83% 330B
ABBVIE INC. Stock AbbVie Inc.
+3.54% 287B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.70% 236B
NOVARTIS AG Stock Novartis AG
+6.68% 202B
ROCHE HOLDING AG Stock Roche Holding AG
-9.08% 197B
AMGEN INC. Stock Amgen Inc.
+6.70% 161B
PFIZER, INC. Stock Pfizer, Inc.
-1.81% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A251120 Stock
  4. Company BIO-FD&C Co.,Ltd.